-transparent.png){kind=logo}
Nifedipine was evaluated in the prophylaxis of 28 patients each of migraine and tension headache using a double blind cross over design with random allocation to drug or placebo group. The duration of the trial was 3 months with a 2 week run-in period and 2 week wash-oat period separating two treatment periods of 4 weeks each. A satisfactory response was obtained in 71.4% of migraineurs (p < 0.001) and 28.6% of patients with tension headache (p = N.S). Minor side effects were observed in 5 patients. Nifedipine is a useful agent for the management of migraine as it reduces frequency and severity of pain but the drug cannot be recommended for tension headache.
Related Publications
R Shukla, and
R K Garg, and
D Nag, and
R C Ahuja
October 1995,
Cephalalgia : an international journal of headache,
R Shukla, and
R K Garg, and
D Nag, and
R C Ahuja
August 1989,
International journal of cardiology,
R Shukla, and
R K Garg, and
D Nag, and
R C Ahuja
January 1988,
Drugs,
R Shukla, and
R K Garg, and
D Nag, and
R C Ahuja
November 1977,
Headache,
R Shukla, and
R K Garg, and
D Nag, and
R C Ahuja
January 2015,
PloS one,
R Shukla, and
R K Garg, and
D Nag, and
R C Ahuja
May 2011,
Cephalalgia : an international journal of headache,
R Shukla, and
R K Garg, and
D Nag, and
R C Ahuja
November 1984,
JAMA,
R Shukla, and
R K Garg, and
D Nag, and
R C Ahuja
August 2009,
The Lancet. Neurology,
R Shukla, and
R K Garg, and
D Nag, and
R C Ahuja
March 1985,
Headache,
R Shukla, and
R K Garg, and
D Nag, and
R C Ahuja
February 2000,
Schmerz (Berlin, Germany),
